349 related articles for article (PubMed ID: 26087080)
1. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
Yadav P; Singal A; Pandhi D; Das S
Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
[TBL] [Abstract][Full Text] [Related]
2. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
4. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
6. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
8. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
[TBL] [Abstract][Full Text] [Related]
9. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Evans EG; Sigurgeirsson B
BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Kejda J
Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
Tausch I; Bräutigam M; Weidinger G; Jones TC
Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
[TBL] [Abstract][Full Text] [Related]
12. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
13. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
[TBL] [Abstract][Full Text] [Related]
14. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
15. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
16. Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole.
Gupta AK; Cooper EA; Paquet M
J Cutan Med Surg; 2013; 17(3):201-6. PubMed ID: 23673304
[TBL] [Abstract][Full Text] [Related]
17. Short term treatment of dermatophyte onychomycosis with terbinafine.
Goodfield MJ; Andrew L; Evans EG
BMJ; 1992 May; 304(6835):1151-4. PubMed ID: 1392793
[TBL] [Abstract][Full Text] [Related]
18. A randomized treatment duration-finding study of terbinafine in onychomycosis.
van der Schroeff JG; Cirkel PK; Crijns MB; Van Dijk TJ; Govaert FJ; Groeneweg DA; Tazelaar DJ; De Wit RF; Wuite J
Br J Dermatol; 1992 Feb; 126 Suppl 39():36-9. PubMed ID: 1531927
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
Elewski B; Pollak R; Ashton S; Rich P; Schlessinger J; Tavakkol A
Br J Dermatol; 2012 Feb; 166(2):389-98. PubMed ID: 21967490
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
